Article Versions Notes

Nitschke C, Markmann B, Tölle M, Kropidlowski J, Belloum Y, Goetz MR, Schlüter H, Kwiatkowski M, Sinn M, Izbicki J, et al. Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients. Cancers. 2022; 14(18):4405. https://doi.org/10.3390/cancers14184405

Nitschke, Christine, Benedikt Markmann, Marie Tölle, Jolanthe Kropidlowski, Yassine Belloum, Mara R. Goetz, Hartmut Schlüter, Marcel Kwiatkowski, Marianne Sinn, Jakob Izbicki, and et al. 2022. "Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients" Cancers 14, no. 18: 4405. https://doi.org/10.3390/cancers14184405

Nitschke, C., Markmann, B., Tölle, M., Kropidlowski, J., Belloum, Y., Goetz, M. R., Schlüter, H., Kwiatkowski, M., Sinn, M., Izbicki, J., Pantel, K., Güngör, C., Uzunoglu, F. G., & Wikman, H. (2022). Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients. Cancers, 14(18), 4405. https://doi.org/10.3390/cancers14184405